SLC2A2 and nonpapillary renal cell carcinoma: Our study demonstrates that in ccRCC, S100A2 functions as a cofactor assisting the transcription factor HNF1A in promoting GLUT2 expression, thereby enhancing glycolysis and driving tumor progression.